Test Detail
American Bully Pack: Progressive Retinal Atrophy (crd1-PRA) + Cystinuria + Hyperuricosuria (HUU/SLC) + Neuronal Ceroid Lipofuscinosis (NCL) + Degenerative Myelopathy (DM exon 2)
General · Dog
Genetic panel for the American Bully grouping five recessive hereditary conditions prevalent in bull/pit-type breeds: crd1-type progressive retinal atrophy (crd1-PRA, early photoreceptor degeneration), cystinuria (cystine stones in the urinary tract), hyperuricosuria/hyperuricaemia (HUU, risk of urate uroliths), neuronal ceroid lipofuscinosis (NCL, neurodegenerative degeneration of adult onset) and degenerative myelopathy (DM, exon 2 variant of SOD1). The American Bully descends from the American Staffordshire Terrier and shares several variants through a founder effect.
Incidence
American Bully (and related pit/bull-type breeds). ARSG-related NCL is characterised in AmStaff/APBT (allele at 3.4 % in AmStaff, Donner 2023 n>1M); it is assumed to be shared with the American Bully by ancestry, with no published cases in the breed. For crd1-PRA, HUU and cystinuria in the American Bully, population figures are not reliably published (limited data).
Breeder management
- Genotype breeding animals for PDE6B, SLC2A9, ARSG, SOD1 exon 2 and the cystinuria variant before mating\n- Do not cross two carriers for the same variant\n- A carrier may be crossed with a clear animal and the offspring intended for breeding must be tested\n- After a confirmed case, do not repeat the parental cross and communicate the status to the buyer\n- For HUU and cystinuria, recommend diet and management (low purine, low methionine) even if the test is positive, and urinary monitoring\n- Remember that DM has incomplete penetrance: not all SOD1 homozygotes develop disease
Specialist notes
crd1-PRA must be distinguished from other PRAs (prcd-PRA, etc.); the crd1 test does not exclude other forms. ARSG-related NCL has an adult presentation and must be differentiated from other degenerative ataxias. Cystinuria and HUU share a clinical presentation (urolithiasis) and require stone analysis. DM is only attributable to SOD1 after ruling out spinal cord compression (MRI, myelography).
References
1. Kijas JW et al. (2004). Cloning of the canine ABCA4 gene and evaluation in canine cone-rod dystrophies and progressive retinal atrophies. Mol Vis 10:223-232. PMID: 15064680
2. Goldstein O et al. (2013). IQCB1 and PDE6B mutations cause similar early onset retinal degenerations in two closely related terrier dog breeds. Invest Ophthalmol Vis Sci 54:7005-19. PMID: 24045995
3. Abitbol M et al. (2010). A canine arylsulfatase G (ARSG) mutation leading to a sulfatase deficiency is associated with neuronal ceroid lipofuscinosis. Proc Natl Acad Sci USA 107:14775-80. PMID: 20679209
4. Donner J et al. (2023). Genetic prevalence and clinical relevance of canine Mendelian disease variants in over one million dogs. PLoS Genet. PMID: 36848397
5. Harnevik L et al. (2006). SLC7A9 cDNA cloning and mutational analysis of SLC3A1 and SLC7A9 in canine cystinuria. Mamm Genome. PMID: 16845473
6. Ruggerone B et al. (2016). Genetic evaluation of English bulldogs with cystine uroliths. Vet Rec. PMID: 27388977
7. Fitzwilliams C et al. (2023). Evaluation of the value of genetic testing for cystinuria in the Danish population of English bulldogs. Anim Genet. PMID: 36971195
8. Brons AK et al. (2013). SLC3A1 and SLC7A9 mutations in autosomal recessive or dominant canine cystinuria: a new classification system. J Vet Intern Med. PMID: 24001348
9. Bannasch D et al. (2008). Mutations in the SLC2A9 gene cause hyperuricosuria and hyperuricemia in the dog. PLoS Genet. PMID: 18989453
10. Awano T et al. (2009). Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy. Proc Natl Acad Sci USA. PMID: 19188595
OMIA001674-9615 / OMIA000256-9615 / OMIA001033-9615 / OMIA001503-9615 / OMIA000263-9615.
2. Goldstein O et al. (2013). IQCB1 and PDE6B mutations cause similar early onset retinal degenerations in two closely related terrier dog breeds. Invest Ophthalmol Vis Sci 54:7005-19. PMID: 24045995
3. Abitbol M et al. (2010). A canine arylsulfatase G (ARSG) mutation leading to a sulfatase deficiency is associated with neuronal ceroid lipofuscinosis. Proc Natl Acad Sci USA 107:14775-80. PMID: 20679209
4. Donner J et al. (2023). Genetic prevalence and clinical relevance of canine Mendelian disease variants in over one million dogs. PLoS Genet. PMID: 36848397
5. Harnevik L et al. (2006). SLC7A9 cDNA cloning and mutational analysis of SLC3A1 and SLC7A9 in canine cystinuria. Mamm Genome. PMID: 16845473
6. Ruggerone B et al. (2016). Genetic evaluation of English bulldogs with cystine uroliths. Vet Rec. PMID: 27388977
7. Fitzwilliams C et al. (2023). Evaluation of the value of genetic testing for cystinuria in the Danish population of English bulldogs. Anim Genet. PMID: 36971195
8. Brons AK et al. (2013). SLC3A1 and SLC7A9 mutations in autosomal recessive or dominant canine cystinuria: a new classification system. J Vet Intern Med. PMID: 24001348
9. Bannasch D et al. (2008). Mutations in the SLC2A9 gene cause hyperuricosuria and hyperuricemia in the dog. PLoS Genet. PMID: 18989453
10. Awano T et al. (2009). Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy. Proc Natl Acad Sci USA. PMID: 19188595
OMIA001674-9615 / OMIA000256-9615 / OMIA001033-9615 / OMIA001503-9615 / OMIA000263-9615.